Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Molecular Cancer Therapeutics
|
May 8, 2015
BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume
Nicholas Theodosakis, Matthew A Held, Alexander Marzuka-Alcala, et al.
The Oncologist
|
March 30, 2021
Risk of COVID-19 in Patients with Cancer Receiving Immune Checkpoint Inhibitors
Nikolai Klebanov, Vartan Pahalyants, William S Murphy, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
January 22, 2009
Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer
Matthew D Taylor, Philip W Smith, William K Brix, et al.
JAMA Dermatology
|
January 7, 2026
Validation of International Classification of Diseases Codes for Dermatologic Conditions: A Systematic Review
Debby Cheng, Nora Bensellam, Katherine Sanchez, et al.
Oncotarget
|
October 21, 2015
SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells
Casey G Langdon, Norbert Wiedemann, Matthew A Held, et al.
Journal for Immunotherapy of Cancer
|
June 15, 2022
Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study
Bruce C Tiu, Leyre Zubiri, James Iheke, et al.
Cancer Cell
|
January 14, 2015
mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation
William Damsky, Goran Micevic, Katrina Meeth, et al.
Science Advances
|
April 3, 2021
Reduced MC4R signaling alters nociceptive thresholds associated with red hair
Kathleen C Robinson, Lajos V Kemény, Gillian L Fell, et al.
Journal of the American Academy of Dermatology
|
February 24, 2023
Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy
Nga Nguyen, Guihong Wan, Pearl Ugwu-Dike, et al.
Biorxiv : the Preprint Server for Biology
|
December 25, 2025
UV induces common cutaneous amyloid-like melanosomal protein aggregates
Nicholas Theodosakis, Porter B Howland, Miroslav Hejna, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Molecular Cancer Therapeutics
|
May 8, 2015
BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume
Nicholas Theodosakis, Matthew A Held, Alexander Marzuka-Alcala, et al.
The Oncologist
|
March 30, 2021
Risk of COVID-19 in Patients with Cancer Receiving Immune Checkpoint Inhibitors
Nikolai Klebanov, Vartan Pahalyants, William S Murphy, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
January 22, 2009
Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer
Matthew D Taylor, Philip W Smith, William K Brix, et al.
JAMA Dermatology
|
January 7, 2026
Validation of International Classification of Diseases Codes for Dermatologic Conditions: A Systematic Review
Debby Cheng, Nora Bensellam, Katherine Sanchez, et al.
Oncotarget
|
October 21, 2015
SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells
Casey G Langdon, Norbert Wiedemann, Matthew A Held, et al.
Journal for Immunotherapy of Cancer
|
June 15, 2022
Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study
Bruce C Tiu, Leyre Zubiri, James Iheke, et al.
Cancer Cell
|
January 14, 2015
mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation
William Damsky, Goran Micevic, Katrina Meeth, et al.
Science Advances
|
April 3, 2021
Reduced MC4R signaling alters nociceptive thresholds associated with red hair
Kathleen C Robinson, Lajos V Kemény, Gillian L Fell, et al.
Journal of the American Academy of Dermatology
|
February 24, 2023
Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy
Nga Nguyen, Guihong Wan, Pearl Ugwu-Dike, et al.
Biorxiv : the Preprint Server for Biology
|
December 25, 2025
UV induces common cutaneous amyloid-like melanosomal protein aggregates
Nicholas Theodosakis, Porter B Howland, Miroslav Hejna, et al.
Page
of 6